Findings from a study exploring how AI-driven NCCN guideline interpretation can optimize genetic testing and reduce clinician burden in prostate cancer.
David M. Waterhouse, MD, MPH
Advertisement
Articles by David M. Waterhouse, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Dostarlimab in Previously Untreated Locally Advanced Rectal Cancer
2
Ris-Rez Produces Anti-Tumor Activity in Extensive-Stage SCLC
3
Is Vitamin C an Epigenetic Interception Strategy in Pre-Leukemic Disease?
4
AI Foundation Models & Molecular Biomarkers in Breast Cancer
5